Mohammad Movassaghi

Professor

Department
Department of Chemistry
Technology Areas
Chemicals & Materials: Catalysis & Synthesis / Therapeutics: Small Molecules / Biotechnology: Biomanufacturing

Technologies

Synthesis and Anti-cancer Activity of Communesin Alkaloids

Technology / Case number: #21462
Mohammad Movassaghi / Matthew Pompeo / Jaime Cheah
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Synthesis of Potent Epidithiodiketopiperazines Designed for Facile Derivatization

Technology / Case number: #21469
Mohammad Movassaghi / Joshua Payette / Jaime Cheah / Chase Olsson / Tony Scott
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Use of Synthetic ETPs in Reversing Cancer Chemoresistance

Technology / Case number: #22888J
Mohammad Movassaghi / Vikas Sukhatme / Mo Motamedi / Junichi Hanai
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Compounds, Compositions, and Methods of Macrocyclic Depsipeptide Antibiotics

Technology / Case number: #23104
Mohammad Movassaghi / Bradley Pentelute / Carly Schissel / Kyan D'Angelo
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Convergent and Biomimetic Enantioselective Total Synthesis of (-)-Communesin F

Technology / Case number: #18676
Mohammad Movassaghi / Stephen Lathrop / Matthew Pompeo / Wen-Tau Chang
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis

Technology / Case number: #19505J
Mohammad Movassaghi / Rachel Buchsbaum / Alyssa Antropow / Kun Xu
Technology Areas: Therapeutics
License

Diazene Directed Modular Synthesis of Oligocyclotryptamines

Technology / Case number: #18747
Mohammad Movassaghi / Petra Lindovska
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.